about
Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia.Inducible heat shock protein 70 expression as a potential predictive marker of metastasis in breast tumors.Mechanisms of Translocation of ER Chaperones to the Cell Surface and Immunomodulatory Roles in Cancer and Autoimmunity.Facets of heat shock protein 70 show immunotherapeutic potential.Enhanced antitumoral efficacy and immune response following conditionally replicative adenovirus containing constitutive HSF1 delivery to rodent tumors.Serum proteome analysis for profiling protein markers associated with carcinogenesis and lymph node metastasis in nasopharyngeal carcinoma.Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heat shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killer cells.Photodynamic therapy and the role of heat shock protein 70.Repression of IRF-4 target genes in human T cell leukemia virus-1 infection.CAMKIIγ, HSP70 and HSP90 transcripts are differentially expressed in chronic myeloid leukemia cells from patients with resistant mutated disease.Membrane HSP70: the molecule triggering gammadelta T cells in the early stage of tumorigenesis.Preparation of a heat-shock protein 70-based vaccine from DC-tumor fusion cells.Immunomodulatory effects of radiofrequency ablation in a breast cancer model.Mimotope-hormesis and mortalin/grp75/mthsp70: a new hypothesis on how infectious disease-associated epitope mimicry may explain low cancer burden in developing nations.A Novel Heat Shock Protein 70-based Vaccine Prepared from DC-Tumor Fusion Cells.Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cells.Peripheral leukocyte response to oncological radiotherapy: expression of heat shock proteins.
P2860
Q34179630-E2C2B29F-9C8D-4238-ACC6-364CA489AC44Q34451153-B569735D-B1C0-4153-9060-614AB594B9ACQ35025948-A572312E-87EC-4283-8F48-27F9F927F674Q35206769-F8AB98C6-9E7C-44BA-9993-A4B5CF8DA1C5Q36165809-2F7F119E-382D-42A8-9F6F-22B4D753AF5EQ36700050-92BB7CF4-0DA0-4EED-9A44-24E872ED485FQ37490479-B22D1FB9-28ED-4019-BD35-E6AFEC5DE1C1Q37941740-A086B120-66BB-4BFD-9918-40E0282B85BDQ38362324-E54B1DD9-8B14-4CA8-9C55-E580E5F22F52Q39065654-0EFA0E6D-F86F-4E79-AAB1-ACC7BBF6D053Q40348659-2E8BCB41-40CF-416E-BF7C-572A88197FC8Q42726581-92DFCAC5-B6B2-436A-B0B9-5F7F47EC082EQ43197760-1722EC48-7AB5-4220-A9F8-27290D23F038Q45266365-8112D30E-4791-43BF-9687-0038953BE8B0Q47362481-E67B864D-9E2A-47BD-9AE6-9593AAA0E783Q50930404-FDB363A5-CE7F-4A8D-BE11-E9F95072417EQ54605703-11794BF2-C6CA-4AD0-A006-1AB75A82418E
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The inducible Hsp70 as a marker of tumor immunogenicity
@ast
The inducible Hsp70 as a marker of tumor immunogenicity
@en
type
label
The inducible Hsp70 as a marker of tumor immunogenicity
@ast
The inducible Hsp70 as a marker of tumor immunogenicity
@en
prefLabel
The inducible Hsp70 as a marker of tumor immunogenicity
@ast
The inducible Hsp70 as a marker of tumor immunogenicity
@en
P2860
P1476
The inducible Hsp70 as a marker of tumor immunogenicity
@en
P2093
P2860
P304
P356
10.1379/1466-1268(2001)006<0121:TIHAAM>2.0.CO;2
P577
2001-04-01T00:00:00Z